Glabellar Neuromodulator 2406-103

Main Concern: Glabellar Lines
Main Concern Explanation: This study looks to reduce glabellar lines with a new neuromodulator.
Study Specifics: This trial will evaluate the safety and effectiveness of a new type of neuromodulator to treat moderate to severe glabellar lines compared to a placebo.
Duration: 8-9 Visits Over 6 Months
Compensation: TBD